# Aminopterin Dose Finding Treatment for Methotrexate-Naïve Rheumatoid Arthritis

> **NCT01724931** · PHASE2 · COMPLETED · sponsor: **Syntrix Biosystems, Inc.** · enrollment: 175 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** LD-aminopterin
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01724931
- **Lead sponsor:** Syntrix Biosystems, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02
- **Primary completion:** 2014-09
- **Final completion:** 2015-02
- **Target enrollment:** 175 (ACTUAL)
- **Last updated:** 2015-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01724931

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01724931, "Aminopterin Dose Finding Treatment for Methotrexate-Naïve Rheumatoid Arthritis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01724931. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*